NHS Approves First New Ovarian Cancer Drug in 20 Years

Hundreds of women with hard-to-treat ovarian cancer will now receive a groundbreaking new therapy that extends life while dramatically reducing the debilitating side effects of traditional chemotherapy.

The approval marks the first new ovarian cancer treatment on the NHS in two decades.